摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-2-(dimethylamino)-2-[(Z)-octadec-9-enyl]icos-11-enoic acid

中文名称
——
中文别名
——
英文名称
(Z)-2-(dimethylamino)-2-[(Z)-octadec-9-enyl]icos-11-enoic acid
英文别名
——
(Z)-2-(dimethylamino)-2-[(Z)-octadec-9-enyl]icos-11-enoic acid化学式
CAS
——
化学式
C40H77NO2
mdl
——
分子量
604.0
InChiKey
OFMOVWGVULBMHZ-WRBBJXAJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    14.3
  • 重原子数:
    43
  • 可旋转键数:
    34
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Process for formulating an anionic agent
    申请人:Dicerna Pharmaceuticals, Inc.
    公开号:US10137201B2
    公开(公告)日:2018-11-27
    Formulations comprising anionic agents such as nucleic acids within a lipid-containing particle methods of formulating a lipid-containing particle comprising an anionic agent such as a nucleic acid, methods for preparing a lipid-containing particle comprising an anionic agent such as a nucleic acid, methods for therapeutic delivery of an anionic agent to a patient in need thereof, where the anionic agent is formulated in a lipid-containing particle as described herein.
    包含阴离子剂(如含脂微粒中的核酸)的制剂 配制包含阴离子剂(如核酸)的含脂微粒的方法、制备包含阴离子剂(如核酸)的含脂微粒的方法、向有需要的患者治疗递送阴离子剂的方法,其中阴离子剂被配制在本文所述的含脂微粒中。
  • PROCESS FOR FORMULATING AN ANIONIC AGENT
    申请人:Dicerna Pharmaceuticals, Inc.
    公开号:EP2968149A1
    公开(公告)日:2016-01-20
  • [EN] PROCESS FOR FORMULATING AN ANIONIC AGENT<br/>[FR] PROCÉDÉ DE FORMULATION D'UN AGENT ANIONIQUE
    申请人:DICERNA PHARMACEUTICALS INC
    公开号:WO2014153163A1
    公开(公告)日:2014-09-25
    Formulations comprising anionic agents such as nucleic acids within a lipid-containing particle methods of formulating a lipid-containing particle comprising an anionic agent such as a nucleic acid, methods for preparing a lipid-containing particle comprising an anionic agent such as a nucleic acid, methods for therapeutic delivery of an anionic agent to a patient in need thereof, where the anionic agent is formulated in a lipid-containng particle as described herein.
查看更多